Talaris Therapeutics Inc
NASDAQ:TALS
Earnings Announcements
Talaris Therapeutics Announces First Quarter Results
Published: 05/12/2022 20:59 GMT
Talaris Therapeutics Inc (TALS) - Talaris Therapeutics Announces First Quarter Financial Results and Corporate Update.
Q1 Loss per Share $0.45.
Q1 Loss per Share $0.45.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.46
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.49
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.46
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.49
More details on our Analysts Page.